KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) Debt to Equity (2017 - 2026)

ClearPoint Neuro's Debt to Equity history spans 13 years, with the latest figure at $1.75 for Q4 2025.

  • On a quarterly basis, Debt to Equity changed N/A to $1.75 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.75, a N/A change, with the full-year FY2025 number at $1.75, changed N/A from a year prior.
  • Debt to Equity hit $1.75 in Q4 2025 for ClearPoint Neuro, down from $1.84 in the prior quarter.
  • Over the last five years, Debt to Equity for CLPT hit a ceiling of $1.84 in Q3 2025 and a floor of $0.2 in Q4 2021.
  • Historically, Debt to Equity has averaged $0.61 across 4 years, with a median of $0.36 in 2021.
  • Biggest five-year swings in Debt to Equity: crashed 98.08% in 2021 and later skyrocketed 75.2% in 2023.
  • Tracing CLPT's Debt to Equity over 4 years: stood at $0.2 in 2021, then skyrocketed by 33.0% to $0.27 in 2022, then skyrocketed by 75.2% to $0.47 in 2023, then skyrocketed by 272.75% to $1.75 in 2025.
  • Business Quant data shows Debt to Equity for CLPT at $1.75 in Q4 2025, $1.84 in Q3 2025, and $1.46 in Q2 2025.